S&P 500   2,713.16 (+1.86%)
DOW   23,189.40 (+2.25%)
QQQ   198.85 (+1.21%)
FB   169.21 (+2.21%)
MSFT   164.70 (-0.34%)
GOOGL   1,193.55 (+0.88%)
AMZN   2,012.01 (+0.72%)
CGC   14.94 (+4.18%)
NVDA   265.09 (-1.23%)
BABA   198.55 (+1.07%)
MU   46.47 (-0.41%)
T   30.34 (+3.06%)
GILD   73.97 (-4.84%)
DIS   102.75 (+3.18%)
PRI   89.73 (+2.87%)
S&P 500   2,713.16 (+1.86%)
DOW   23,189.40 (+2.25%)
QQQ   198.85 (+1.21%)
FB   169.21 (+2.21%)
MSFT   164.70 (-0.34%)
GOOGL   1,193.55 (+0.88%)
AMZN   2,012.01 (+0.72%)
CGC   14.94 (+4.18%)
NVDA   265.09 (-1.23%)
BABA   198.55 (+1.07%)
MU   46.47 (-0.41%)
T   30.34 (+3.06%)
GILD   73.97 (-4.84%)
DIS   102.75 (+3.18%)
PRI   89.73 (+2.87%)
S&P 500   2,713.16 (+1.86%)
DOW   23,189.40 (+2.25%)
QQQ   198.85 (+1.21%)
FB   169.21 (+2.21%)
MSFT   164.70 (-0.34%)
GOOGL   1,193.55 (+0.88%)
AMZN   2,012.01 (+0.72%)
CGC   14.94 (+4.18%)
NVDA   265.09 (-1.23%)
BABA   198.55 (+1.07%)
MU   46.47 (-0.41%)
T   30.34 (+3.06%)
GILD   73.97 (-4.84%)
DIS   102.75 (+3.18%)
PRI   89.73 (+2.87%)
S&P 500   2,713.16 (+1.86%)
DOW   23,189.40 (+2.25%)
QQQ   198.85 (+1.21%)
FB   169.21 (+2.21%)
MSFT   164.70 (-0.34%)
GOOGL   1,193.55 (+0.88%)
AMZN   2,012.01 (+0.72%)
CGC   14.94 (+4.18%)
NVDA   265.09 (-1.23%)
BABA   198.55 (+1.07%)
MU   46.47 (-0.41%)
T   30.34 (+3.06%)
GILD   73.97 (-4.84%)
DIS   102.75 (+3.18%)
PRI   89.73 (+2.87%)
Log in

NASDAQ:CRSPCrispr Therapeutics News Headlines

$42.38
+0.21 (+0.50 %)
(As of 04/7/2020 10:38 AM ET)
Add
Compare
Today's Range
$42.32
Now: $42.38
$43.86
50-Day Range
$33.68
MA: $46.13
$58.11
52-Week Range
$32.30
Now: $42.38
$74.00
Volume136,545 shs
Average Volume943,224 shs
Market Capitalization$2.58 billion
P/E Ratio43.69
Dividend YieldN/A
Beta2.53

Headlines

Crispr Therapeutics (NASDAQ CRSP) News Headlines

Source:
DateHeadline
Why Adaptimmune Therapeutics, Atreca, and CRISPR Therapeutics All Tanked In MarchWhy Adaptimmune Therapeutics, Atreca, and CRISPR Therapeutics All Tanked In March
www.msn.com - April 6 at 4:24 PM
Is CRISPR Therapeutics Stock a Buy?Is CRISPR Therapeutics Stock a Buy?
www.fool.com - April 5 at 3:55 PM
Piper Sandler Reiterates "Buy" Rating for Crispr Therapeutics (NASDAQ:CRSP)Piper Sandler Reiterates "Buy" Rating for Crispr Therapeutics (NASDAQ:CRSP)
www.americanbankingnews.com - April 2 at 4:42 PM
Crispr Therapeutics AG (NASDAQ:CRSP) Sees Large Growth in Short InterestCrispr Therapeutics AG (NASDAQ:CRSP) Sees Large Growth in Short Interest
www.americanbankingnews.com - April 1 at 7:20 AM
First Week of May 8th Options Trading For CRISPR Therapeutics (CRSP)First Week of May 8th Options Trading For CRISPR Therapeutics (CRSP)
www.nasdaq.com - March 30 at 4:24 PM
Hedge Funds Have Never Been This Bullish On CRISPR Therapeutics AG (CRSP)Hedge Funds Have Never Been This Bullish On CRISPR Therapeutics AG (CRSP)
finance.yahoo.com - March 27 at 2:22 PM
 Brokerages Anticipate Crispr Therapeutics AG (NASDAQ:CRSP) Will Announce Quarterly Sales of $6.35 Million Brokerages Anticipate Crispr Therapeutics AG (NASDAQ:CRSP) Will Announce Quarterly Sales of $6.35 Million
www.americanbankingnews.com - March 27 at 4:43 AM
 Analysts Expect Crispr Therapeutics AG (NASDAQ:CRSP) Will Announce Earnings of -$1.09 Per Share Analysts Expect Crispr Therapeutics AG (NASDAQ:CRSP) Will Announce Earnings of -$1.09 Per Share
www.americanbankingnews.com - March 25 at 6:26 AM
Crispr Therapeutics AG (NASDAQ:CRSP) Sees Significant Growth in Short InterestCrispr Therapeutics AG (NASDAQ:CRSP) Sees Significant Growth in Short Interest
www.americanbankingnews.com - March 15 at 6:34 AM
Crispr Therapeutics AG (NASDAQ:CRSP) Receives Consensus Recommendation of "Buy" from BrokeragesCrispr Therapeutics AG (NASDAQ:CRSP) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - March 14 at 2:18 AM
CRISPR Therapeutics Enters Oversold Territory (CRSP)CRISPR Therapeutics Enters Oversold Territory (CRSP)
www.nasdaq.com - March 12 at 2:46 PM
CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should KnowCRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know
finance.yahoo.com - March 10 at 7:40 PM
Researchers Create New CRISPR Gene-Editing System for PlantsResearchers Create New CRISPR Gene-Editing System for Plants
www.fool.com - March 9 at 10:20 PM
CRSP Mar 2020 53.500 callCRSP Mar 2020 53.500 call
finance.yahoo.com - March 7 at 8:40 AM
CRSP April 24th Options Begin TradingCRSP April 24th Options Begin Trading
www.nasdaq.com - March 5 at 3:30 PM
Horrible Week Finally Comes to an EndHorrible Week Finally Comes to an End
finance.yahoo.com - March 2 at 11:42 AM
Can CRISPR Therapeutics Double Your Money in 2020?Can CRISPR Therapeutics Double Your Money in 2020?
www.fool.com - February 28 at 8:50 AM
CRISPR Should Continue The Bullish Pace From 2019CRISPR Should Continue The Bullish Pace From 2019
seekingalpha.com - February 23 at 2:05 PM
Stock To Watch: CRISPR Therapeutics (CRSP)Stock To Watch: CRISPR Therapeutics (CRSP)
www.nasdaq.com - February 13 at 1:29 PM
CRISPR Therapeutics EPS beats by $1.19, beats on revenueCRISPR Therapeutics EPS beats by $1.19, beats on revenue
seekingalpha.com - February 12 at 9:29 PM
CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should KnowCRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know
finance.yahoo.com - February 12 at 9:29 PM
CRISPR Therapeutics AG (CRSP) Beats Q4 Earnings and Revenue EstimatesCRISPR Therapeutics AG (CRSP) Beats Q4 Earnings and Revenue Estimates
finance.yahoo.com - February 12 at 9:29 PM
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial ResultsCRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - February 12 at 4:28 PM
CRISPR Therapeutics Shows Market Leadership With Jump To 92 RS RatingCRISPR Therapeutics Shows Market Leadership With Jump To 92 RS Rating
finance.yahoo.com - February 11 at 5:32 PM
First CRISPR Gene Editing Trial in Cancer Patients Shows Promising ResultsFirst CRISPR Gene Editing Trial in Cancer Patients Shows Promising Results
www.fool.com - February 7 at 6:15 PM
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should KnowCRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
finance.yahoo.com - February 6 at 7:09 PM
Heres Why CRISPR Stocks Fell in JanuaryHere's Why CRISPR Stocks Fell in January
www.fool.com - February 5 at 1:31 PM
CRISPR Therapeutics AG (CRSP) Stock Moves -0.9%: What You Should KnowCRISPR Therapeutics AG (CRSP) Stock Moves -0.9%: What You Should Know
finance.yahoo.com - January 31 at 10:44 PM
Vertex (VRTX) Q4 Earnings Beat on Solid CF Product SalesVertex (VRTX) Q4 Earnings Beat on Solid CF Product Sales
finance.yahoo.com - January 31 at 5:44 PM
March 13th Options Now Available For CRISPR Therapeutics (CRSP)March 13th Options Now Available For CRISPR Therapeutics (CRSP)
www.nasdaq.com - January 30 at 2:26 PM
RSI Alert: CRISPR Therapeutics (CRSP) Now OversoldRSI Alert: CRISPR Therapeutics (CRSP) Now Oversold
www.nasdaq.com - January 23 at 3:58 PM
Misplaced Assumptions, Where Investments Go WrongMisplaced Assumptions, Where Investments Go Wrong
seekingalpha.com - January 21 at 8:57 PM
3 Top Biotech Picks for 20203 Top Biotech Picks for 2020
www.fool.com - January 20 at 1:47 PM
European ruling threatens Broads CRISPR gene-editing patentsEuropean ruling threatens Broad's CRISPR gene-editing patents
www.bizjournals.com - January 17 at 5:30 PM
European ruling threatens Broad's CRISPR gene-editing patentsEuropean ruling threatens Broad's CRISPR gene-editing patents
finance.yahoo.com - January 17 at 5:30 PM
SCANS: The FAANG of The Roaring 20sSCANS: The FAANG of The Roaring 20s
finance.yahoo.com - January 14 at 9:31 PM
Heres Why CRISPR Therapeutics Stock Jumped 113.2% in 2019Here's Why CRISPR Therapeutics Stock Jumped 113.2% in 2019
www.fool.com - January 9 at 5:52 PM
These Top Fund Managers Outperform With Stocks That Many Other Investors AvoidThese Top Fund Managers Outperform With Stocks That Many Other Investors Avoid
finance.yahoo.com - January 6 at 4:32 PM
CRISPR Therapeutics to Present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top ConferenceCRISPR Therapeutics to Present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top Conference
finance.yahoo.com - January 6 at 4:32 PM
Is Intellia Therapeutics Stock a Buy?Is Intellia Therapeutics Stock a Buy?
www.fool.com - January 5 at 10:00 AM
Better Buy: Crispr Therapeutics vs. EditasBetter Buy: Crispr Therapeutics vs. Editas
www.fool.com - January 4 at 8:02 AM
CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should KnowCRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know
finance.yahoo.com - January 3 at 10:01 PM
Intellia Therapeutics: A Look Back At 2019 And Forward To 2020Intellia Therapeutics: A Look Back At 2019 And Forward To 2020
seekingalpha.com - January 2 at 1:21 PM
Better Buy: Editas Medicine vs. CRISPR TherapeuticsBetter Buy: Editas Medicine vs. CRISPR Therapeutics
www.nasdaq.com - December 27 at 12:19 PM
This CRISPR Stock Is A 2020 Top Pick — But Will Gene Editing Succeed?This CRISPR Stock Is A 2020 Top Pick — But Will Gene Editing Succeed?
finance.yahoo.com - December 20 at 12:03 PM
If You Had Bought CRISPR Therapeutics (NASDAQ:CRSP) Stock Three Years Ago, You Could Pocket A 212% Gain TodayIf You Had Bought CRISPR Therapeutics (NASDAQ:CRSP) Stock Three Years Ago, You Could Pocket A 212% Gain Today
finance.yahoo.com - December 20 at 7:03 AM
This Start-up Might Be the Next Gene Editing IPOThis Start-up Might Be the Next Gene Editing IPO
www.fool.com - December 19 at 10:55 AM
Did Hedge Funds Drop The Ball On CRISPR Therapeutics AG (CRSP) ?Did Hedge Funds Drop The Ball On CRISPR Therapeutics AG (CRSP) ?
finance.yahoo.com - December 11 at 5:27 PM
What the Tech?What the Tech?
finance.yahoo.com - December 11 at 5:27 PM
Repare Therapeutics Appoints Steve Forte as CFO and Samarth Kulkarni to Its Board of DirectorsRepare Therapeutics Appoints Steve Forte as CFO and Samarth Kulkarni to Its Board of Directors
finance.yahoo.com - December 3 at 10:35 PM
This page was last updated on 4/7/2020 by MarketBeat.com Staff

Featured Article: Margin

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel